Janus Henderson Group’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$615K	Hold	47,957	–	–	﹤0.01%	1916
2025 Q4	$431K	Hold	47,957	–	–	﹤0.01%	2070
2025 Q3	$827K	Hold	47,957	–	–	﹤0.01%	1757
2025 Q2	$449K	Hold	47,957	–	–	﹤0.01%	2001
2025 Q1	$387K	Hold	47,957	–	–	﹤0.01%	2090
2024 Q4	$560K	Hold	47,957	–	–	﹤0.01%	1981
2024 Q3	$985K	Buy	47,957 +10,575	+28%	+$244K	﹤0.01%	1676
2024 Q2	$837K	Sell	37,382 -459	-1%	-$10.9K	﹤0.01%	1715
2024 Q1	$1.04M	Buy	37,841 +6	+0%	+$167	﹤0.01%	1623
2023 Q4	$1.15M	Sell	37,835 -38	-0.1%	-$1.09K	﹤0.01%	1547
2023 Q3	$1.2M	Buy	37,873 +2	+0%	+$78	﹤0.01%	1465
2023 Q2	$1.54M	Buy	37,871 +6,572	+21%	+$267K	﹤0.01%	1377
2023 Q1	$1.17M	Sell	31,299 -22,846	-42%	-$896K	﹤0.01%	1543
2022 Q4	$1.89M	Buy	54,145 +29,283	+118%	+$1.39M	﹤0.01%	1114
2022 Q3	$1.39M	Buy	24,862 +12,425	+100%	+$771K	﹤0.01%	1479
2022 Q2	$644K	Buy	12,437 +17	+0.1%	+$863	﹤0.01%	1596
2022 Q1	$902K	Sell	12,420 -258,581	-95%	-$21.9M	﹤0.01%	1561
2021 Q4	$32M	Sell	271,001 -6,826	-2%	-$855K	0.01%	677
2021 Q3	$37.3M	Buy	277,827 +24,730	+10%	+$3.74M	0.02%	634
2021 Q2	$41M	Buy	253,097 +217,437	+610%	+$16.9M	0.02%	623
2021 Q1	$2.86M	Buy	+35,660	New	+$2.39M	﹤0.01%	1123